At this stage, one cannot exclude the activation by certain oncogenes such as WT1 which are highly expressed in ovarian cancer [28] and known to increase AMHRII expression by one of its isotypes designated “–KTS” [29]. This evidence concerns the gene WT1 and ovarian carcinoma.